Alpha Centric Advisors LLC Fulgent Genetics, Inc. Transaction History

Alpha Centric Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$28.52 - $40.7 $14,260 - $20,350	-500 Reduced 1.27%	39,000 $1.44 Million
Q4 2022 Feb 07, 2023	BUY	$29.23 - $40.28 $263,070 - $362,520	9,000 Added 29.51%	39,500 $1.18 Million
Q3 2022 Nov 08, 2022	BUY	$37.92 - $63.74 $1.16 Million - $1.94 Million	30,500 New	30,500 $1.16 Million

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Centric Advisors LLC with notifications on news.